⌘K
Loading ticker…
As of 2026-08-24, HCW Biologics Inc. Common Stock (HCWB) has a 3-month relative strength percentile of 2 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 25. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 16.4%, relative volume 2.28×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
HCWB is in a stage 4 downtrend, week 2. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -44.2% / -64.0%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
HCWB appears in 1 ETF as of Mar 2026: VXF at 0.00% weight, $4K notional.
Held by 1 ETFs · $4K across latest filings · largest weight 0.00% (VXF).
Top 1 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VXFVanguard Extended Market ETF | 0.00% | $4K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | HCWB Jan avg: -7.02% median: -2.40% win: 50% σ: 22.10% n: 4 2022-04-12 → 2026-07-31 | HCWB Feb avg: 1.49% median: 10.30% win: 50% σ: 39.97% n: 4 2022-04-12 → 2026-07-31 | HCWB Mar avg: -15.58% median: -23.98% win: 25% σ: 23.56% n: 4 2022-04-12 → 2026-07-31 | HCWB Apr avg: -8.33% median: -20.00% win: 40% σ: 25.00% n: 5 2022-04-12 → 2026-07-31 | HCWB May avg: 56.87% median: -4.09% win: 40% σ: 147.47% n: 5 2022-04-12 → 2026-07-31 | HCWB Jun avg: -18.38% median: -40.64% win: 40% σ: 45.27% n: 5 2022-04-12 → 2026-07-31 | HCWB Jul avg: -6.60% median: -5.99% win: 40% σ: 17.84% n: 5 2022-04-12 → 2026-07-31 | HCWB Aug avg: 1.85% median: -1.94% win: 50% σ: 25.46% n: 4 2022-04-12 → 2026-07-31 (current) | HCWB Sep avg: -6.03% median: -2.90% win: 50% σ: 22.60% n: 4 2022-04-12 → 2026-07-31 | HCWB Oct avg: -7.32% median: -6.88% win: 25% σ: 10.80% n: 4 2022-04-12 → 2026-07-31 | HCWB Nov avg: -19.30% median: -20.74% win: 25% σ: 25.52% n: 4 2022-04-12 → 2026-07-31 | HCWB Dec avg: -13.89% median: -7.39% win: 25% σ: 28.66% n: 4 2022-04-12 → 2026-07-31 |